DaVita HealthCare Net Worth
DaVita HealthCare Net Worth Breakdown | DVA |
DaVita HealthCare Net Worth Analysis
DaVita HealthCare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including DaVita HealthCare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of DaVita HealthCare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform DaVita HealthCare's net worth analysis. One common approach is to calculate DaVita HealthCare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares DaVita HealthCare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing DaVita HealthCare's net worth. This approach calculates the present value of DaVita HealthCare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of DaVita HealthCare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate DaVita HealthCare's net worth. This involves comparing DaVita HealthCare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into DaVita HealthCare's net worth relative to its peers.
Enterprise Value |
|
To determine if DaVita HealthCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding DaVita HealthCare's net worth research are outlined below:
| About 49.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 8078 shares by Kathleen Waters of DaVita HealthCare at 108.93 subject to Rule 16b-3 |
DaVita HealthCare Quarterly Good Will |
|
DaVita HealthCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in DaVita HealthCare Partners. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to DaVita HealthCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know DaVita HealthCare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DaVita HealthCare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DaVita HealthCare Partners backward and forwards among themselves. DaVita HealthCare's institutional investor refers to the entity that pools money to purchase DaVita HealthCare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Allianz Asset Management Ag | 2024-06-30 | 538.7 K | Charles Schwab Investment Management Inc | 2024-09-30 | 501.6 K | Jpmorgan Chase & Co | 2024-06-30 | 470.1 K | Bank Of America Corp | 2024-06-30 | 452.6 K | Bank Of New York Mellon Corp | 2024-06-30 | 446.5 K | Citadel Advisors Llc | 2024-09-30 | 433.8 K | Legal & General Group Plc | 2024-06-30 | 432 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 408.7 K | Hrt Financial Llc | 2024-06-30 | 383.8 K | Berkshire Hathaway Inc | 2024-06-30 | 36.1 M | Vanguard Group Inc | 2024-09-30 | 5.4 M |
Follow DaVita HealthCare's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 13.59 B.Market Cap |
|
Project DaVita HealthCare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.07 | |
| Return On Capital Employed | 0.11 | 0.15 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.65 | 0.69 |
When accessing DaVita HealthCare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures DaVita HealthCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of DaVita HealthCare's profitability and make more informed investment decisions.
Please note, the presentation of DaVita HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DaVita HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of DaVita HealthCare's management manipulating its earnings.
Evaluate DaVita HealthCare's management efficiency
DaVita HealthCare has Return on Asset of 0.0694 % which means that on every $100 spent on assets, it made $0.0694 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.4488 %, implying that it generated $0.4488 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, DaVita HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Assets are forecasted to decline to 0.04. At present, DaVita HealthCare's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 762.2 M, whereas Total Assets are forecasted to decline to about 10.2 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 30.22 | 31.73 | |
| Tangible Book Value Per Share | (50.36) | (47.84) | |
| Enterprise Value Over EBITDA | 8.63 | 10.88 | |
| Price Book Value Ratio | 9.01 | 9.46 | |
| Enterprise Value Multiple | 8.63 | 10.88 | |
| Price Fair Value | 9.01 | 9.46 | |
| Enterprise Value | 19.4 B | 20.4 B |
The leadership approach at DaVita HealthCare's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Enterprise Value Revenue 1.9494 | Revenue 12.7 B | Quarterly Revenue Growth 0.046 | Revenue Per Share 145.293 | Return On Equity 0.4488 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DaVita HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on DaVita HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DaVita HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DaVita HealthCare Corporate Filings
F4 | 27th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 29th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 24th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 14th of June 2024 Other Reports | ViewVerify |
DaVita HealthCare Earnings per Share Projection vs Actual
DaVita HealthCare Corporate Directors
| Paul Diaz | Independent Director | Profile | |
| John Nehra | Independent Director | Profile | |
| Phyllis Yale | Independent Director | Profile | |
| Pascal Desroches | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 9.28 | Revenue Per Share 145.293 | Quarterly Revenue Growth 0.046 | Return On Assets 0.0694 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.